206 related articles for article (PubMed ID: 1854214)
21. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents].
Inaba M
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1449-56. PubMed ID: 1906701
[TBL] [Abstract][Full Text] [Related]
23. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
24. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
[TBL] [Abstract][Full Text] [Related]
25. [Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system].
Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1227-34. PubMed ID: 3729446
[TBL] [Abstract][Full Text] [Related]
26. Similarity of serum-tumor pharmacokinetics of antitumor agents in man and nude mice.
Kubota T; Inoue S; Furukawa T; Ishibiki K; Kitajima M; Kawamura E; Hoffman RM
Anticancer Res; 1993; 13(5A):1481-4. PubMed ID: 8239525
[TBL] [Abstract][Full Text] [Related]
27. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
29. [Enhancement of antitumor activity of mitomycin C against human breast carcinoma xenografts by pretreatment with KM 2210].
Yamamoto T; Kubota T; Oka S; Josui K; Fujita S; Arisawa Y; Suto A; Inoue S; Kuzuoka M; Ishibiki K
Gan To Kagaku Ryoho; 1990 Jan; 17(1):109-14. PubMed ID: 2105084
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
Geiger T; Müller M; Monia BP; Fabbro D
Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
[TBL] [Abstract][Full Text] [Related]
31. [Clinical studies on a rapid screening assay for anticancer agents with nude mice and isotopic evaluation].
Nosoh Y; Nishiyama M; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1221-6. PubMed ID: 3729445
[TBL] [Abstract][Full Text] [Related]
32. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
[TBL] [Abstract][Full Text] [Related]
35. Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity.
Bousquet PF; Braña MF; Conlon D; Fitzgerald KM; Perron D; Cocchiaro C; Miller R; Moran M; George J; Qian XD
Cancer Res; 1995 Mar; 55(5):1176-80. PubMed ID: 7867004
[TBL] [Abstract][Full Text] [Related]
36. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
38. [Studies on antitumor activity of rhEndostatin].
Li HY; Li Y; Liu ZH; Wu HJ; Chen FH; Chen XG
Yao Xue Xue Bao; 2002 Oct; 37(10):763-6. PubMed ID: 12567857
[TBL] [Abstract][Full Text] [Related]
39. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibitory effects of pMC540 and merodantoin on established MCF-7 human breast tumor xenografts.
Sharma R; Gulliya KS
In Vivo; 1995; 9(2):103-8. PubMed ID: 7548784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
